中文 | English
Return
Total: 1571 , 1/158
Show Home Prev Next End page: GO
Author:( Xue XIA)

1.Biomimetic nanoparticle delivery systems b ased on red blood cell membranes for disease treatment

Chen-xia GAO ; Yan-yu XIAO ; Yu-xue-yuan CHEN ; Xiao-liang REN ; Mei-ling CHEN

Acta Pharmaceutica Sinica 2025;60(2):348-358

2.Efficacy and safety of vericiguat added to GDMT regimen in the treatment of heart failure with reduced ejection fraction

Xingyuan ZHAO ; Xiangyan CHEN ; Nan HU ; Liying WANG ; Hui XUE ; Zongling XIA

China Pharmacy 2025;36(17):2165-2169

3.A case report and literature review on anakinra in the treatment of refractory adult onset Still’s disease

Yumin YAN ; Jie LIU ; Xia ZHANG ; Xue ZHONG

China Pharmacy 2025;36(19):2442-2447

4.Application of augmented reality technology combined with transcranial Doppler ultrasound in nursing teaching of cerebrovascular diseases

Yongmei XU ; Na CHEN ; Jun HU ; Xue ZHANG ; Xiaolin XIA ; Haoyu TANG ; Cui WANG

Chinese Journal of Medical Education Research 2024;23(4):522-527

5.Effect of CXCL7/CXCR2 axis on synaptic plasticity in obesity-related cognitive dysfunction

Jia HU ; Ao-Xue XU ; Rui HU ; Qi XUE ; Chun-Xia HUANG ; Ye ZHANG

Chinese Pharmacological Bulletin 2024;40(5):881-886

6.Mechanism of Xiyanping injection in treatment of acute lung injury using network pharmacology and molecular docking analysis

Shao-Yan NIE ; Su-Su FAN ; Yu-Shan ZHU ; Xue-Rong PENG ; Ying-Xia WANG ; Xuan ZHANG

Chinese Pharmacological Bulletin 2024;40(6):1165-1171

7.The intervention effect of Dahuang Tangluo Pills on diabetic kidney disease based on NLRP3/caspase-1/GSDMD pathway mediated pyroptosis

Chun-Xia XUE ; Yuan-Yuan ZHANG ; Xia YANG ; Pu ZHANG ; Bei-Bei SU ; Xiang-Dong ZHU ; Jian-Qing LIANG

Chinese Pharmacological Bulletin 2024;40(8):1552-1558

8.Exploring mechanism of action of Xihuang pills against hyperplasia of mammary glands based on quantitative proteomics

Rui TAO ; Jing-Rui WANG ; Jun-Liang WANG ; Xue-Li MA ; Juan-Xia SUN ; Guang-Miao GAO ; Qi-Rui FAN ; Tao HAN

Chinese Pharmacological Bulletin 2024;40(9):1641-1648

9.Establishment and validation of an In Vitro evaluation system for human liver UDP-glucuronosyltransferase activity and drug inhibition study

Jing ZHANG ; Hang LI ; Xue-Xia ZHANG ; Shuai-Bing LIU

Chinese Pharmacological Bulletin 2024;40(10):1990-1996

10.Molecular evolution of human infection with H9N2 subtype avian influenza virus in Anhui province from 2013 to 2022

Yidan XIA ; Sitian YANG ; Minhao HU ; Xue ZHOU ; Junling YU ; Wanrong LUO ; Weixi FANG ; Jun HE

Chinese Journal of Experimental and Clinical Virology 2024;38(5):527-532

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 1571 , 1/158 Show Home Prev Next End page: GO